earnings

NASDAQ · AKTX
Akari Therapeutics, Plc
Healthcare · Biotechnology
$10.12
Down-$0.25 (-2.42%)
Updated Sep 17, 2026, 10:30 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.22K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.13 – $29.32
- Volume
- 16.37K
- Avg. volume
- 1.09M
Price performance
AKTX price history
1M range · 20 trading sessions · Daily adjusted prices
AKTX closed at $10.12 after 20 trading sessions, up 28.10% for the selected period.
- Last close
- $10.12
- Period change
- +28.10%
- Period low
- $7.47
- Period high
- $11.47
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $11.00 | $11.00 | $9.78 | $10.12 | 16.37K |
| Sep 15, 2026 | $11.05 | $11.05 | $10.00 | $10.25 | 27.59K |
| Sep 14, 2026 | $11.43 | $11.61 | $10.68 | $11.04 | 39.99K |
| Sep 11, 2026 | $10.51 | $11.50 | $10.51 | $11.30 | 135.28K |
| Sep 10, 2026 | $10.63 | $11.065 | $10.07 | $10.88 | 166.03K |
| Sep 9, 2026 | $10.89 | $12.15 | $10.0187 | $10.57 | 131.07K |
| Sep 8, 2026 | $11.32 | $12.04 | $10.75 | $10.96 | 128.54K |
| Sep 4, 2026 | $10.41 | $11.82 | $10.1703 | $11.47 | 108.91K |
| Sep 3, 2026 | $10.00 | $11.40 | $9.65 | $10.84 | 61.95K |
| Sep 2, 2026 | $10.09 | $10.40 | $9.60 | $10.15 | 46.5K |
| Sep 1, 2026 | $10.44 | $10.50 | $9.44 | $10.37 | 174.97K |
| Aug 31, 2026 | $10.62 | $11.40 | $9.75 | $10.43 | 81.4K |
| Aug 28, 2026 | $8.93 | $11.08 | $8.80 | $10.70 | 168.63K |
| Aug 27, 2026 | $9.60 | $9.60 | $8.75 | $9.01 | 54.08K |
| Aug 26, 2026 | $8.10 | $9.9599 | $7.95 | $9.10 | 254.84K |
| Aug 25, 2026 | $7.97 | $8.10 | $7.6901 | $7.87 | 30.41K |
| Aug 24, 2026 | $8.00 | $8.06 | $7.355 | $7.47 | 41.37K |
| Aug 21, 2026 | $8.095 | $8.10 | $7.70 | $7.85 | 10.99K |
| Aug 20, 2026 | $8.10 | $8.10 | $7.6901 | $7.79 | 16.54K |
| Aug 19, 2026 | $7.85 | $8.10 | $7.70 | $7.90 | 15.25K |
Latest AKTX news
The latest Smart Investors Daily articles mentioning AKTX.
Stock researchResearch & News · SID Coverage
Loading stock research…

